Cargando…
Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: (18)F-FAU, (18)F-FMAU, and (18)F-FLT
BACKGROUND: A principal goal for the use of positron emission tomography (PET) in oncology is for real-time evaluation of tumor response to chemotherapy. Given that many contemporary anti-neoplastic agents function by impairing cellular proliferation, it is of interest to develop imaging modalities...
Autores principales: | McHugh, Christopher I., Lawhorn-Crews, Jawana M., Modi, Dipenkumar, Douglas, Kirk A., Jones, Steven K., Mangner, Thomas J., Collins, Jerry M., Shields, Anthony F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067904/ https://www.ncbi.nlm.nih.gov/pubmed/27751167 http://dx.doi.org/10.1186/s40644-016-0092-2 |
Ejemplares similares
-
Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[(18)F]-Fluoro-L-Thymidine ([(18)F]FLT) Positron Emission Tomography (PET)
por: Ullrich, Roland T., et al.
Publicado: (2008) -
The relationship between endogenous thymidine concentrations and [(18)F]FLT uptake in a range of preclinical tumour models
por: Heinzmann, Kathrin, et al.
Publicado: (2016) -
Extramedullary haematopoiesis imaging with (18)F-FLT PET
por: Agool, Ali, et al.
Publicado: (2010) -
Glucose–Thymidine Ratio as a Metabolism Index Using (18)F-FDG and (18)F-FLT PET Uptake as a Potential Imaging Biomarker for Evaluating Immune Checkpoint Inhibitor Therapy
por: Oh, Sera, et al.
Publicado: (2022) -
Correction to: The relationship between endogenous thymidine concentrations and [(18)F]FLT uptake in a range of preclinical tumour models
por: Heinzmann, Kathrin, et al.
Publicado: (2017)